{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T21:12:13Z","timestamp":1766005933244,"version":"3.48.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.euo.2025.11.004","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T21:08:50Z","timestamp":1766005730000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Evaluation of a Novel Deintensified Surveillance Protocol for Low-risk Non\u2013muscle-invasive Bladder Cancer: A Prospective Study in 250 Patients"],"prefix":"10.1016","author":[{"given":"Chandrarajan Premal","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya","family":"Lord-McKenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8221-4640","authenticated-orcid":false,"given":"Paramananthan","family":"Mariappan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2025.11.004_b0005","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"Burger","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.11.004_b0010","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.eururo.2015.10.024","article-title":"Economic burden of bladder cancer across the European Union","volume":"69","author":"Leal","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.11.004_b0015","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.annonc.2021.11.012","article-title":"Bladder cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"33","author":"Powles","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.euo.2025.11.004_b0020","doi-asserted-by":"crossref","first-page":"e418","DOI":"10.1016\/j.clgc.2019.12.004","article-title":"Effects of bladder cancer on UK healthcare costs and patient health-related quality of life: evidence from the BOXIT trial","volume":"18","author":"Cox","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.euo.2025.11.004_b0025","series-title":"Presented at the EAU Annual Congress Madrid 2025","author":"Guidelines","year":"2025"},{"key":"10.1016\/j.euo.2025.11.004_b0030","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1097\/01.ju.0000149163.08521.69","article-title":"A surveillance schedule for G1Ta bladder cancer allowing efficient use of check cystoscopy and safe discharge at 5 years based on a 25-year prospective database","volume":"173","author":"Mariappan","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.11.004_b0035","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.eururo.2005.03.014","article-title":"Urine markers for bladder cancer surveillance: a systematic review","volume":"47","author":"van Rhijn","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.11.004_b0040","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.euros.2023.12.006","article-title":"The value of negative urinary dipstick tests for haematuria in patients undergoing surveillance for low-grade Ta urothelial cancer: a two-stage prospective clinical study in 524 patients","volume":"60","author":"Shah","year":"2024","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euo.2025.11.004_b0045","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.euf.2021.07.011","article-title":"The scottish bladder cancer quality performance indicators influencing outcomes, prognosis, and surveillance (Scot BC Quality OPS) clinical project","volume":"7","author":"Mariappan","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2025.11.004_b0050","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.eururo.2019.10.010","article-title":"Non-visible haematuria for the detection of bladder, upper tract, and kidney cancer: an updated systematic review and meta-analysis","volume":"77","author":"Jubber","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.11.004_b0055","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41585-021-00441-9","article-title":"Attention to detail and a permissive set-up: crucial for an effective TURBT","volume":"18","author":"Mariappan","year":"2021","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euo.2025.11.004_b0060","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.urolonc.2007.06.002","article-title":"UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing","volume":"26","author":"Hajdinjak","year":"2008","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2025.11.004_b0065","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0022-5347(01)61899-8","article-title":"Comparison of screening methods in the detection of bladder cancer","volume":"161","author":"Ramakumar","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.11.004_b0070","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0022-5347(05)67916-5","article-title":"A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice","volume":"163","author":"Khadra","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.11.004_b0075","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/S0022-5347(05)68075-5","article-title":"Long-term followup of initial Ta grade 1 transitional cell carcinoma of the bladder","volume":"162","author":"Leblanc","year":"1999","journal-title":"J Urol"},{"issue":"2 Pt 1","key":"10.1016\/j.euo.2025.11.004_b0080","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/01.ju.0000076621.71247.6c","article-title":"Expectant management of small, recurrent, noninvasive papillary bladder tumors","volume":"170","author":"Soloway","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.11.004_b0085","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.juro.2006.10.048","article-title":"Pattern of recurrence changes in noninvasive bladder tumors observed during 2 decades","volume":"177","author":"Mariappan","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.11.004_b0090","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.euf.2023.06.012","article-title":"Long-term recurrence rates of low-risk non-muscle-invasive bladder cancer\u2014how long is cystoscopic surveillance necessary?","volume":"10","author":"Ma","year":"2024","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2025.11.004_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2025.101198","article-title":"Assessing the clinical efficacy of neoadjuvant intravesical mitomycin C in na\u00efve non-muscle invasive urinary bladder cancer: a systematic review and meta-analysis","volume":"55","author":"Thakur","year":"2025","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.euo.2025.11.004_b0100","doi-asserted-by":"crossref","first-page":"66.e25","DOI":"10.1016\/j.urolonc.2014.06.008","article-title":"Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer","volume":"33","author":"Yafi","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2025.11.004_b0105","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.urolonc.2009.12.002","article-title":"Feasibility study of screening for bladder cancer with urinary molecular markers (the BLU-P project)","volume":"28","author":"Roobol","year":"2010","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2025.11.004_b0110","doi-asserted-by":"crossref","first-page":"163.e1","DOI":"10.1016\/j.urolonc.2021.08.017","article-title":"Xpert bladder cancer monitor in surveillance of bladder cancer: systematic review and meta-analysis","volume":"40","author":"Sharma","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2025.11.004_b0115","doi-asserted-by":"crossref","first-page":"12489","DOI":"10.3390\/ijms241512489","article-title":"Bladder Epicheck test: a novel tool to support urothelial carcinoma diagnosis in urine samples","volume":"24","author":"Fiorentino","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125002925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125002925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T21:08:52Z","timestamp":1766005732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931125002925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":23,"alternative-id":["S2588931125002925"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2025.11.004","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Evaluation of a Novel Deintensified Surveillance Protocol for Low-risk Non\u2013muscle-invasive Bladder Cancer: A Prospective Study in 250 Patients","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2025.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}